Arix Bioscience business LogicBio files for US IPO

26th Sep 2018 13:59

(Sharecast News) - Healthcare and life science company Arix Bioscience announced on Wednesday that one of its group businesses, genome editing company LogicBio Therapeutics, has filed a registration statement with the US Securities and Exchange Commission for a proposed initial public offering in the United States.The London-listed firm said all shares to be sold in the offering would be offered by LogicBio, which planned to list its common stock on the Nasdaq Global Market under the ticker symbol 'LOGC'.It said the number of shares to be sold and the price range per share for the proposed offering had not yet been determined.